Author

OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

AddThis Feed Button

Calendar

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08

« District Court Finds Apotex and Impax Infringe AstraZeneca's Formulation Patents on Prilosec | Main | District Court Invalidates McNeil's Formulation Patent on Pepcid Complete, Relying on KSR v. Teleflex »

June 05, 2007

ACI "Pharma/Biotech Patent Boot Camp" Conference, June 21-22, New York City

American Conference Institute plans to hold a two-day "Pharma/Biotech Patent Boot Camp" on June 21-22 in New York.

According to ACI, the conference "has been designed to give new patent attorneys and patent attorneys who are new to the life sciences industries--as well as business executives in pharma and biotech companies--a strong working knowledge of essential IP and regulatory competencies relative to life sciences patents."

The following talks should be particularly informative:

  • The Nature of the Approval Process for Drugs and Biologics: What Every Life Sciences Patent Attorney Should Know
  • Pre-Patent Considerations: Product Development, Commercialization and Life Cycle Management
  • Freedom to Operate: Review of Analysis and Opinions for Pharma and Biotech Patents
  • Bioequivalence and the "Same Active Ingredient" vis-a-vis Patentability
  • Exploring Pharmaceutical Patent Extensions: Patent Term Adjustment and Patent Term Restoration
  • Perfecting Claims in Life Sciences Patent Applications
  • Understanding the Doctrines of Accidental and Inherent Anticipation and their Impact on Life Sciences Patents
  • The Safe Harbor: Assessing Protections and Identifying Infringing Activities Relative to Life Science Patents

The co-chairs of the conference are Thomas J. Kowalski (partner, Frommer Lawrence & Haug LLP) and Robert B. Nicholas (partner, McDermott Will & Emery LLP).  Additional details and registration information are available at the conference website.

Orange Book Blog is a media partner of this conference.

Posted by Aaron Barkoff in Conferences |

Comments

Myself is an Associate Professor of Law with Doctorate on IPR and Biotechnology from India. I have authored a book on Biotechnology and Patent law, currently working on a new book on Biotechnology law. I am very happy to learn about your conference. Thank you very much

Posted by: Dr. Sreenivasulu N.S, Professor of IPR and Biotechnology | March 17, 2008 at 03:38 AM

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.